Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy

被引:7
作者
Krystyna, Mitosek-Szewczyk [1 ]
Jacek, Tabarkiewicz [2 ]
Sebastian, Radej [2 ]
Ewa, Belniak [1 ]
Halina, Bartosik-Psujek [1 ]
Zbigniew, Stelmasiak [1 ]
Jacek, Rolinski [2 ]
机构
[1] Med Univ Lublin, Dept Neurol, PL-20090 Lublin, Poland
[2] Med Univ Lublin, Dept Immunol, PL-20090 Lublin, Poland
关键词
Dendritic cells; B cell; Multiple sclerosis; Methyloprednisolone; DIFFERENTIATION; PATHOGENESIS; SUBSETS;
D O I
10.1016/j.jneuroim.2008.11.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied dendritic, myeloid (mDCs) (BDCA1+/CD19-) and plasmacytoid cells (pDCs) (BDCA2+/CD123+) and B-cells (CD19+) at relapse, after short intravenous methyloprednisolone therapy and 30 days after treatment completion (remission period) and results were compared with a control group of healthy volunteers. We confirmed the decrease in BDCA2+/CD723+ after therapy (p=0.00006) and then an increase (p=0.0032) in comparison to the control group. The level of B CD19+ cells after GC therapy increased compared to the control group (p=0.00809) and had stabilised 30 days after therapy. The effect of methyloprednisolone on DC function and B-cell levels thus changes. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 13 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis [J].
Corcione, A ;
Casazza, S ;
Ferretti, E ;
Giunti, D ;
Zappia, E ;
Pistorio, A ;
Gambini, C ;
Mancardi, GL ;
Uccelli, A ;
Pistoia, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (30) :11064-11069
[3]  
Duddy M, 2006, Int MS J, V13, P84
[4]   Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis [J].
Duddy, Martin ;
Niino, Masaaki ;
Adatia, Femina ;
Hebert, Sherry ;
Freedman, Mark ;
Atkins, Harry ;
Kim, Ho Jin ;
Bar-Or, Amit .
JOURNAL OF IMMUNOLOGY, 2007, 178 (10) :6092-6099
[5]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[6]  
Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO
[7]  
2-Q
[8]   Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127
[9]   Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse:: Differential short-term changes on corticosteroids therapy [J].
Navarro, Joaquin ;
Aristimuno, Carol ;
Sanchez-Ramon, Silvia ;
Vigil, Dolores ;
Martinez-Gines, Ma. Luisa ;
Fernandez-Cruz, Eduardo ;
de Andres, Clara .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 176 (1-2) :153-161
[10]   Role of B cells in pathogenesis of multiple sclerosis [J].
Nikbin, Behrouz ;
Bonab, Mandana Mohyeddin ;
Khosravi, Farideh ;
Talebian, Fatemeh .
NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 :13-+